Proton pump inhibitors and risk of all‐cause and cause‐specific mortality: A cohort study

UK cohort study (733 885 new users of PPIs; 124 410 new users of H2Ras) found an association between PPI use and all‐cause mortality (HR 1.38, 95% CI 1.33‐1.44), but analyses indicate that residual confounding is likely.

Source:

British Journal of Clinical Pharmacology